BR9810177A - Composto, formulação farmacêutica, uso de um composto, e, processos para tratamento de uma condição onde a inibição da trombina é requerida e para a preparação de compostos - Google Patents
Composto, formulação farmacêutica, uso de um composto, e, processos para tratamento de uma condição onde a inibição da trombina é requerida e para a preparação de compostosInfo
- Publication number
- BR9810177A BR9810177A BR9810177-3A BR9810177A BR9810177A BR 9810177 A BR9810177 A BR 9810177A BR 9810177 A BR9810177 A BR 9810177A BR 9810177 A BR9810177 A BR 9810177A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- treating
- processes
- condition
- pharmaceutical formulation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
"COMPOSTO, FORMULAçãO FARMACêUTICA, USO DE UM COMPOSTO, E, PROCESSOS PARA TRATAMENTO DE UMA CONDIçãO ONDE A INIBIçãO DA TROMBINA é REQUERIDA E PARA A PREPARAçãO DE COMPOSTOS" Forneceu-se compostos da fórmula (I), em que R^ 1^, R~ x~, Y, R^ y^, n e B têm os significados dados na descrição, os quais são utilizáveis como inibidores competitivos das proteases semelhantes à tripsina, tais como a trombina, e em particular no tratamento de condições onde a inibição da trombina é requerida (por exemplo, na trombose) ou como anticoagulantes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702378A SE9702378D0 (sv) | 1997-06-19 | 1997-06-19 | New compounds |
SE9801099A SE9801099D0 (sv) | 1998-03-30 | 1998-03-30 | New compounds |
PCT/SE1998/001103 WO1998057932A1 (en) | 1997-06-19 | 1998-06-09 | New amidino derivatives and their use as thrombin inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9810177A true BR9810177A (pt) | 2000-08-08 |
Family
ID=26663014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9810177-3A BR9810177A (pt) | 1997-06-19 | 1998-06-09 | Composto, formulação farmacêutica, uso de um composto, e, processos para tratamento de uma condição onde a inibição da trombina é requerida e para a preparação de compostos |
Country Status (20)
Country | Link |
---|---|
US (2) | US6265397B1 (pt) |
EP (1) | EP1012140B1 (pt) |
JP (2) | JP3919236B2 (pt) |
KR (1) | KR100540413B1 (pt) |
CN (1) | CN1205187C (pt) |
AR (1) | AR013084A1 (pt) |
AT (1) | ATE277902T1 (pt) |
AU (1) | AU737645C (pt) |
BR (1) | BR9810177A (pt) |
CA (1) | CA2294059C (pt) |
DE (1) | DE69826693T2 (pt) |
EE (1) | EE9900600A (pt) |
IL (1) | IL133490A0 (pt) |
IS (1) | IS5302A (pt) |
NO (1) | NO315156B1 (pt) |
NZ (1) | NZ501635A (pt) |
PL (1) | PL337645A1 (pt) |
SK (1) | SK167099A3 (pt) |
TR (1) | TR199903134T2 (pt) |
WO (1) | WO1998057932A1 (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR013084A1 (es) * | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
SE9704543D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Ab | New compounds |
SE9804313D0 (sv) | 1998-12-14 | 1998-12-14 | Astra Ab | New compounds |
IL143987A (en) | 1999-01-13 | 2005-12-18 | Astrazeneca Ab | Amidinobenzylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and use of such compositions in the preparation of a medicament for the inhibition of thrombin |
AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
EP1059302A1 (en) * | 1999-06-08 | 2000-12-13 | Aventis Pharma Deutschland GmbH | Factor VIIa inhibitors |
SE0000382D0 (sv) | 2000-02-07 | 2000-02-07 | Astrazeneca Ab | New process |
US6403818B1 (en) | 2000-02-28 | 2002-06-11 | Eisai Co., Ltd. | Process for producing α-hydroxy-carbonyl compound |
SE0001803D0 (sv) * | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
US6433186B1 (en) | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
US7129233B2 (en) * | 2000-12-01 | 2006-10-31 | Astrazeneca Ab | Mandelic acid derivatives and their use as thrombin inhibitors |
AR035216A1 (es) | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
CN1307875C (zh) | 2001-04-27 | 2007-04-04 | 宝洁公司 | 用于控制生物膜的化合物、组合物和方法 |
AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
SE0201659D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
SE0201661D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
AU2004233863B2 (en) | 2003-04-24 | 2010-06-17 | Incyte Holdings Corporation | Aza spiro alkane derivatives as inhibitors of metalloproteases |
US7781424B2 (en) * | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
ES2291951T3 (es) * | 2003-11-07 | 2008-03-01 | F. Hoffmann-La Roche Ag | Derivados de benzo (b) (1,4) dioxepina. |
US7524354B2 (en) * | 2005-07-07 | 2009-04-28 | Research Foundation Of State University Of New York | Controlled synthesis of highly monodispersed gold nanoparticles |
UA95788C2 (en) | 2005-12-15 | 2011-09-12 | Ф. Хоффманн-Ля Рош Аг | Fused pyrrole derivatives |
TW200827336A (en) * | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
DE102008007440A1 (de) * | 2008-02-01 | 2009-08-13 | Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg | Aminosäurederivate als Arzneistoffe |
EP2321301A4 (en) * | 2008-06-23 | 2011-09-28 | Astrazeneca Ab | NOVEL HETEROCYCLIC CARBOXAMIDES AS THROMBIN INHIBITORS |
CN104327029A (zh) * | 2014-09-21 | 2015-02-04 | 湖南华腾制药有限公司 | 一种含氧杂环化合物的制备方法 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU178398B (en) | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
HU192646B (en) | 1984-12-21 | 1987-06-29 | Gyogyszerkutato Intezet | Process for preparing new n-alkyl-peptide aldehydes |
CA1341029C (en) | 1985-02-04 | 2000-06-20 | Michael Kolb | Peptidase inhibitors |
US5187157A (en) | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
EP0362002B1 (en) | 1988-09-01 | 1995-07-26 | Merrell Dow Pharmaceuticals Inc. | HIV protease inhibitors |
ZA897515B (en) | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
TW201303B (pt) | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
CA2075154A1 (en) | 1991-08-06 | 1993-02-07 | Neelakantan Balasubramanian | Peptide aldehydes as antithrombotic agents |
SE9102462D0 (sv) | 1991-08-28 | 1991-08-28 | Astra Ab | New isosteric peptides |
NZ245039A (en) | 1991-11-12 | 1994-12-22 | Lilly Co Eli | N-phenylalanyl and n-phenylglycyl derivatives of the dipeptide of l-azetidine-2-carboxylic acid and l-arginine aldehyde; anti-blood clotting compositions |
SE9103612D0 (sv) | 1991-12-04 | 1991-12-04 | Astra Ab | New peptide derivatives |
US5760235A (en) | 1992-03-04 | 1998-06-02 | Gyogyszerkutato Intezet Kft. | Anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for preparation thereof |
TW223629B (pt) | 1992-03-06 | 1994-05-11 | Hoffmann La Roche | |
US5583146A (en) | 1992-12-02 | 1996-12-10 | Bristol-Myers Squibb Company | Heterocyclic thrombin inhibitors |
AU675981B2 (en) | 1992-12-02 | 1997-02-27 | Bristol-Myers Squibb Company | Guanidinyl-substituted heterocyclic thrombin inhibitors |
JPH06340619A (ja) | 1993-05-03 | 1994-12-13 | Bristol Myers Squibb Co | グアニジニルまたはアミジニル置換メチルアミノ複素環トロンビン抑制剤 |
US5783563A (en) | 1993-06-03 | 1998-07-21 | Astra Aktiebolag | Method for treatment or prophylaxis of venous thrombosis |
SE9301916D0 (sv) | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
EP0648780A1 (en) | 1993-08-26 | 1995-04-19 | Bristol-Myers Squibb Company | Heterocyclic thrombin inhibitors |
TW394760B (en) | 1993-09-07 | 2000-06-21 | Hoffmann La Roche | Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same |
AU1025795A (en) | 1994-01-27 | 1995-08-03 | Mitsubishi Chemical Corporation | Prolineamide derivatives |
US5705487A (en) | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
US5707966A (en) | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
US5726159A (en) | 1994-03-04 | 1998-03-10 | Eli Lilly And Company | Antithrombotic agents |
IL112795A (en) | 1994-03-04 | 2001-01-28 | Astrazeneca Ab | Derivatives of peptides as antithrombotic drugs, their preparation, and pharmaceutical preparations containing them |
US5561146A (en) | 1994-06-10 | 1996-10-01 | Bristol-Myers Squibb Company | Modified guanidino and amidino thrombin inhibitors |
DE4421052A1 (de) | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
US5510369A (en) | 1994-07-22 | 1996-04-23 | Merck & Co., Inc. | Pyrrolidine thrombin inhibitors |
DE4443390A1 (de) | 1994-12-06 | 1996-06-13 | Basf Ag | Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten |
MX9705970A (es) | 1995-02-10 | 1997-11-29 | Basf Ag | Inhibidores de trombina. |
BR9607582A (pt) | 1995-02-17 | 1998-07-07 | Basf Ag | Composto e peptídeo ou substância peptidomimética |
US5710130A (en) | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
US5914319A (en) | 1995-02-27 | 1999-06-22 | Eli Lilly And Company | Antithrombotic agents |
EP0820453A4 (en) | 1995-04-04 | 2001-08-29 | Merck & Co Inc | THROMBIN INHIBITORS |
US5629324A (en) * | 1995-04-10 | 1997-05-13 | Merck & Co., Inc. | Thrombin inhibitors |
SA96170106A (ar) | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
AR005245A1 (es) | 1995-12-21 | 1999-04-28 | Astrazeneca Ab | Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion |
AU1990197A (en) | 1996-03-12 | 1997-10-01 | Bristol-Myers Squibb Company | Carbamyl guanidine and amidine prodrugs |
JPH1095898A (ja) | 1996-09-25 | 1998-04-14 | Sumitomo Bakelite Co Ltd | 難燃性樹脂組成物およびこれを用いた積層板 |
SE9602263D0 (sv) | 1996-06-07 | 1996-06-07 | Astra Ab | New amino acid derivatives |
SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
DE19632772A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Benzamidine |
DE19632773A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
AR013084A1 (es) * | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
-
1998
- 1998-06-05 AR ARP980102696A patent/AR013084A1/es not_active Application Discontinuation
- 1998-06-09 BR BR9810177-3A patent/BR9810177A/pt not_active Application Discontinuation
- 1998-06-09 KR KR1019997012009A patent/KR100540413B1/ko not_active IP Right Cessation
- 1998-06-09 SK SK1670-99A patent/SK167099A3/sk unknown
- 1998-06-09 TR TR1999/03134T patent/TR199903134T2/xx unknown
- 1998-06-09 EP EP98929969A patent/EP1012140B1/en not_active Expired - Lifetime
- 1998-06-09 IL IL13349098A patent/IL133490A0/xx not_active IP Right Cessation
- 1998-06-09 AT AT98929969T patent/ATE277902T1/de not_active IP Right Cessation
- 1998-06-09 WO PCT/SE1998/001103 patent/WO1998057932A1/en active IP Right Grant
- 1998-06-09 CA CA002294059A patent/CA2294059C/en not_active Expired - Fee Related
- 1998-06-09 JP JP50426299A patent/JP3919236B2/ja not_active Expired - Fee Related
- 1998-06-09 NZ NZ501635A patent/NZ501635A/en unknown
- 1998-06-09 US US09/091,994 patent/US6265397B1/en not_active Expired - Fee Related
- 1998-06-09 AU AU79461/98A patent/AU737645C/en not_active Ceased
- 1998-06-09 EE EEP199900600A patent/EE9900600A/xx unknown
- 1998-06-09 PL PL98337645A patent/PL337645A1/xx not_active Application Discontinuation
- 1998-06-09 DE DE69826693T patent/DE69826693T2/de not_active Expired - Fee Related
- 1998-06-09 CN CNB988081172A patent/CN1205187C/zh not_active Expired - Fee Related
-
1999
- 1999-12-15 IS IS5302A patent/IS5302A/is unknown
- 1999-12-17 NO NO19996313A patent/NO315156B1/no not_active IP Right Cessation
-
2001
- 2001-04-30 US US09/844,428 patent/US6576657B2/en not_active Expired - Fee Related
-
2006
- 2006-07-10 JP JP2006188906A patent/JP2006321807A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE69826693T2 (de) | 2006-02-16 |
TR199903134T2 (xx) | 2000-07-21 |
CN1266427A (zh) | 2000-09-13 |
US6265397B1 (en) | 2001-07-24 |
NO315156B1 (no) | 2003-07-21 |
AU7946198A (en) | 1999-01-04 |
AU737645C (en) | 2002-03-21 |
IL133490A0 (en) | 2001-04-30 |
JP3919236B2 (ja) | 2007-05-23 |
JP2006321807A (ja) | 2006-11-30 |
AU737645B2 (en) | 2001-08-23 |
CA2294059C (en) | 2008-12-09 |
EE9900600A (et) | 2000-08-15 |
WO1998057932A1 (en) | 1998-12-23 |
NO996313L (no) | 2000-02-21 |
PL337645A1 (en) | 2000-08-28 |
AR013084A1 (es) | 2000-12-13 |
EP1012140A1 (en) | 2000-06-28 |
KR100540413B1 (ko) | 2006-01-12 |
EP1012140B1 (en) | 2004-09-29 |
ATE277902T1 (de) | 2004-10-15 |
US20020022612A1 (en) | 2002-02-21 |
NZ501635A (en) | 2001-09-28 |
JP2002503256A (ja) | 2002-01-29 |
CN1205187C (zh) | 2005-06-08 |
CA2294059A1 (en) | 1998-12-23 |
NO996313D0 (no) | 1999-12-17 |
KR20010013982A (ko) | 2001-02-26 |
US6576657B2 (en) | 2003-06-10 |
IS5302A (is) | 1999-12-15 |
DE69826693D1 (de) | 2004-11-04 |
SK167099A3 (en) | 2000-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9810177A (pt) | Composto, formulação farmacêutica, uso de um composto, e, processos para tratamento de uma condição onde a inibição da trombina é requerida e para a preparação de compostos | |
BR0115861A (pt) | Composto, derivado farmaceuticamente aceitável de um composto, formulação farmacêutica, uso de um composto, métodos de tratamento de uma condição onde a inibição da trombina é requerida e de uma condição onde a terapia anticoagulante é indicada, e, processo para a preparação de um composto | |
BR9813410A (pt) | Composto, formulação farmacêutica, uso de um composto, e, processos de tratamento de uma condição, em que a inibição de trombina é requerida ou desejada, e para a preparação de um composto. | |
BR0007453A (pt) | Composto, formulação farmacêutica, uso de umcomposto, método de tratamento de uma condiçãoonde a inibição da trombina é requerida e,processo de preparação de um composto | |
AR007614A1 (es) | Compuesto derivado de amidino, formulacion farmaceutica que lo incluye, metodos para la elaboracion de medicamentos que contienen a dicho compuesto, yproceso para la preparacion de dicho compuesto. | |
BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
BR0210358A (pt) | Inibidores da protease de hiv, composições contendo os mesmos, seus usos farmacêuticos e materiais para sua sìntese | |
BR0009702A (pt) | Compostos ou seus sais, uso de compostos ou sais, e, formulações farmacêuticas | |
BRPI0312464B8 (pt) | compostos inibidores de tirosina quinases, composições farmacêuticas compreendendo os mesmos, processos para fabricação e usos dos mesmos | |
BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
BR9714082A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto. | |
FI942423A0 (fi) | Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina | |
BR9907886A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processo de tratamento ou profilaxia de doenças inflamatórias, por exemplo asma ou copd. | |
TR199902606T2 (xx) | Farnesil transferaz� engelleyici kinazolinonlar. | |
NO992821L (no) | Ketobenzamider som calpain-inhibitorer | |
BR9907270A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto | |
AR003440A1 (es) | Nuevos derivados de aminoacidos, formulacion farmaceutica que los contiene, uso de dichos derivados para preparar medicamentos y procedimiento para la preparacion de dichos derivados. | |
BR9713465A (pt) | Inibidores metalotprotease de amina cìclica sibstituìda | |
BR9811099A (pt) | Inibidores de urocinase | |
SE9602263D0 (sv) | New amino acid derivatives | |
NO983688L (no) | Serin-protease-inhibitorer | |
AR024138A1 (es) | Inhibidores de la proliferacion celular | |
BR0014804A (pt) | Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto | |
BR0315143A (pt) | Composto, processo para a preparação dos (r) e (s) - enanciÈmeros individuais ou misturas de enanciÈmeros e sais farmaceuticamente aceitáveis de um composto, composição farmacêutica, e, uso de um composto | |
BR9916255A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento de uma condição em que se requer inibição de trombina e para a preparação de compostos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 31/401, A61K 31/4025, A61K 31/435, A61K 31/397, A61P 7/02 Ipc: C07D 207/16 (2008.04), A61K 31/40 (2008.04) |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |